Design, Synthesis and Evaluation of Hesperetin Derivatives As Potential Multifunctional Anti-Alzheimer Agents

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2017 Jul 5

PMID 28672874

Citations 9

Authors

Bo Li

Ai-Ling Huang

Yi-Long Zhang

Zeng Li

Hai-Wen Ding

Cheng Huang

Xiao-Ming Meng

Jun Li

Affiliations

Soon will be listed here.

Abstract

In this study we designed and synthesized a series of new hesperetin derivatives on the basis of the structural characteristics of acetylcholinesterase (AChE) dual-site inhibitors. The activity of the novel derivatives was also evaluated. Results showed that the synthesized hesperetin derivatives displayed stronger inhibitory activity against AChE and higher selectivity than butyrylcholine esterase (BuChE) (selectivity index values from 68 to 305). The Lineweaver-Burk plot and molecular docking study showed that these compounds targeted both the peripheral anionic site (PAS) and catalytic active site (CAS) of AChE. The derivatives also showed a potent self-induced β-amyloid (Aβ) aggregation inhibition and a peroxyl radical absorbance activity. Moreover, compound significantly protected PC12 neurons against H₂O₂-induced cell death at low concentrations. Cytotoxicity assay showed that the low concentration of the derivatives does not affect the viability of the SH-SY5Y neurons. Thus, these hesperetin derivatives are potential multifunctional agents for further development for the treatment of Alzheimer's disease.

Citing Articles

An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities.

Khan S, Akhtar M, Gogoi U, Unnikrishnan Meenakshi D, Das A Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259329 PMC: 9961747. DOI: 10.3390/ph16020179.

Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An and Approach.

Comakli V, Aygul I, Saglamtas R, Kuzu M, Demirdag R, Akincioglu H Curr Comput Aided Drug Des. 2023; 20(5):441-451.

PMID: 37202895 DOI: 10.2174/1573409919666230518151414.

Amorphous System of Hesperetin and Piperine-Improvement of Apparent Solubility, Permeability, and Biological Activities.

Wdowiak K, Miklaszewski A, Pietrzak R, Cielecka-Piontek J Int J Mol Sci. 2023; 24(5).

PMID: 36902286 PMC: 10002548. DOI: 10.3390/ijms24054859.

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis.

Walczak-Nowicka L, Herbet M Int J Mol Sci. 2021; 22(17).

PMID: 34502198 PMC: 8430571. DOI: 10.3390/ijms22179290.

Design, Synthesis and Investigation of the Potential Anti-Inflammatory Activity of 7--Amide Hesperetin Derivatives.

Zhang Y, Zheng Y, Shi W, Guo Y, Xu T, Li Z Molecules. 2019; 24(20).

PMID: 31614601 PMC: 6832651. DOI: 10.3390/molecules24203663.

References

Elshazly S, Mahmoud A . Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats. Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(6):559-67. DOI: 10.1007/s00210-014-0968-2. View

Wang B, Mai Y, Li Y, Hou J, Huang S, Ou T . Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors. Eur J Med Chem. 2010; 45(4):1415-23. DOI: 10.1016/j.ejmech.2009.12.044. View

Bolognesi M, Minarini A, Rosini M, Tumiatti V, Melchiorre C . From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease. Mini Rev Med Chem. 2008; 8(10):960-7. DOI: 10.2174/138955708785740652. View

Wilmsen P, Spada D, Salvador M . Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem. 2005; 53(12):4757-61. DOI: 10.1021/jf0502000. View

Rampa A, Belluti F, Gobbi S, Bisi A . Hybrid-based multi-target ligands for the treatment of Alzheimer's disease. Curr Top Med Chem. 2011; 11(22):2716-30. DOI: 10.2174/156802611798184409. View

Qiang X, Sang Z, Yuan W, Li Y, Liu Q, Bai P . Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem. 2014; 76:314-31. DOI: 10.1016/j.ejmech.2014.02.045. View

Lopez-Perez M, Ballester A, Gonzalez-Candelas L . Identification and functional analysis of Penicillium digitatum genes putatively involved in virulence towards citrus fruit. Mol Plant Pathol. 2014; 16(3):262-75. PMC: 6638479. DOI: 10.1111/mpp.12179. View

Yang F, Lim G, Begum A, Ubeda O, Simmons M, Ambegaokar S . Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2004; 280(7):5892-901. DOI: 10.1074/jbc.M404751200. View

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J . Amyloid-beta: a crucial factor in Alzheimer's disease. Med Princ Pract. 2014; 24(1):1-10. PMC: 5588216. DOI: 10.1159/000369101. View

10.

Kandemirli F, Saracoglu M, Kovalishyn V . Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study. Mini Rev Med Chem. 2005; 5(5):479-87. DOI: 10.2174/1389557053765529. View

11.

Bartolini M, Bertucci C, Bolognesi M, Cavalli A, Melchiorre C, Andrisano V . Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action. Chembiochem. 2007; 8(17):2152-61. DOI: 10.1002/cbic.200700427. View

12.

Smith R, Pontiggia L, Waterman C, Lichtenwalner M, Wasserman J . Comparison of motility, recovery, and methyl-thiazolyl-tetrazolium reduction assays for use in screening plant products for anthelmintic activity. Parasitol Res. 2009; 105(5):1339-43. DOI: 10.1007/s00436-009-1560-4. View

13.

Yu Q, Zhu X, Holloway H, Whittaker N, Brossi A, Greig N . Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. J Med Chem. 2002; 45(17):3684-91. DOI: 10.1021/jm010491d. View

14.

Shaik J, Palaka B, Penumala M, Kotapati K, Devineni S, Eadlapalli S . Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. Eur J Med Chem. 2015; 107:219-32. DOI: 10.1016/j.ejmech.2015.10.046. View

15.

Pratico D, Sung S . Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis. 2004; 6(2):171-5. DOI: 10.3233/jad-2004-6209. View

16.

Wang J, Zhu H, Yang Z, Liu Z . Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian J Pharmacol. 2013; 45(4):395-8. PMC: 3757611. DOI: 10.4103/0253-7613.115015. View

17.

Khunnawutmanotham N, Chimnoi N, Saparpakorn P, Techasakul S . Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives. Bioorg Chem. 2016; 65:137-45. DOI: 10.1016/j.bioorg.2015.12.002. View

18.

Mushtaq G, Greig N, Khan J, Kamal M . Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets. 2014; 13(8):1432-9. PMC: 5878042. DOI: 10.2174/1871527313666141023141545. View

19.

Liston D, Nielsen J, Villalobos A, Chapin D, Jones S, Hubbard S . Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur J Pharmacol. 2004; 486(1):9-17. DOI: 10.1016/j.ejphar.2003.11.080. View

20.

Luo W, Wang T, Hong C, Yang Y, Chen Y, Cen J . Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents. Eur J Med Chem. 2016; 122:17-26. DOI: 10.1016/j.ejmech.2016.06.022. View